Results 61 to 70 of about 679 (99)

[Clinical experience with erenumab during the first year of treatment]. [PDF]

Rev Neurol, 2022
Caso-González A, Leralta-González C, Sanz-Alonso V, Iturbe-Heras M, Hernando-de la Bárcena I, Obaldia-Alaña C.   +5 more
europepmc   +1 more source

[CefaleApp: A Mobile Application for Migraine Diagnosis in Primary Health Care]. [PDF]

Rev Neurol
García-Estévez DA, Pérez-Schofield BG, Sabbagh Casado NA.   +2 more
europepmc   +1 more source

[Medication Review with Follow-up Service provided by the Community Pharmacy as a care practice for the optimization of pharmacotherapy in patient with urticaria and pruritus]. [PDF]

Farm Comunitarios, 2023
Pérez Rodríguez RO, Barreto Corujo NJ.
europepmc   +1 more source

[Influence of Clinical and Demographic Variables on the Characteristics of Migraine Attacks]. [PDF]

Rev Neurol
Quintas S, Sánchez NA, Gonzalez-Martinez A, Campos AV, Pagán J, Ayala JL, Galvez-Goicuría J, Sobrado M, Vivancos J, Gago-Veiga AB.   +9 more
europepmc   +1 more source

Gepants: Key Features of A Potent Therapeutic Option and Considerations in The Latin American Context. [PDF]

Rev Neurol
Patiño DR, Zapata JC, Aguirre ALV.
europepmc   +1 more source

[Descriptive study of the alterations in neuroimaging tests in patients with headache in an outpatient setting]. [PDF]

Rev Neurol, 2023
García-Alcántara G, Pérez-Trapote F, López-Rebolledo R, Moreno-López C, Mayo-Canalejo D.   +4 more
europepmc   +1 more source

[Cognitive-Behavioral therapy for patients with disability associated with chronic pain: systematic review of clinical trials] [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Granizo Lara L, Carvajal Granizo V, Reyes Izurieta Á.   +2 more
europepmc   +1 more source

[Headache attributed to ischaemic stroke. An update on its semiology and diagnosis]. [PDF]

Rev Neurol, 2023
Rodríguez-Montolio J, Mateo-Polo M, Jiménez-Jara E, Santos-Lasaosa S.   +3 more
europepmc   +1 more source

[Successful Management of Wearing-off effect with Eptinezumab: Lessons from a case with Chronic Migraine Refractory to Two Subcutaneous CGRP Antibodies]. [PDF]

Rev Neurol
Polanco Fernández M, Gangas Barranquero L, González-Quintanilla V, Madera Fernández J, Pascual J.   +4 more
europepmc   +1 more source

[Hemiplegic migraine: classic findings in a rare pathology]. [PDF]

Rev Neurol
Klaic-López DA, Páez-Granda D, Romero-Carvajal F.   +2 more
europepmc   +1 more source